Non-estrogenic approaches for the treatment of climacteric symptoms

Climacteric

Volumn 10, Issue SUPPL. 2, 2007, Pages 115-120

  Albertazzi, P ^a  

^a Abacus Clinics for Contraception and Reproductive Health   (United Kingdom)

Author keywords

CLimacteric symptoms; Gabapentin; Neurotransmitter modulators; Plant derived remedies; Progestogen

Indexed keywords

BETA ENDORPHIN; CIMICIFUGA RACEMOSA EXTRACT; CITALOPRAM; CONJUGATED ESTROGEN; DESVENLAFAXINE; ESTROGEN; FLUOXETINE; GABAPENTIN; GESTAGEN; GINSENG EXTRACT; ISOFLAVONE DERIVATIVE; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; PAROXETINE; PLACEBO; PRIMROSE OIL; RED CLOVER EXTRACT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ANGELICA SINENSIS; AUTONOMIC NEUROPATHY; BODY MASS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG DEPENDENCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG SYNTHESIS; EVENING PRIMROSE; EVIDENCE BASED PRACTICE; EXERCISE; GINSENG; HOT FLUSH; HUMAN; LONG TERM CARE; MENOPAUSAL SYNDROME; MOOD CHANGE; PRIORITY JOURNAL; RED CLOVER; RISK FACTOR; SOYBEAN; THERMOREGULATION; TRADITIONAL MEDICINE; VASOMOTOR DISORDER; WITHDRAWAL SYNDROME;

AMINES; CYCLOHEXANECARBOXYLIC ACIDS; ESTROGENS, NON-STEROIDAL; EXERCISE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HOT FLASHES; HUMANS; LIBIDO; LIFE STYLE; MENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; WOMEN'S HEALTH;

EID: 34548815432     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130701440980     Document Type: Conference Paper

References (34)

1. Seaman B. The Greatest Experiment ever Performed on Women: Exploding the Estrogen Myth. Iyperion, 2003
2. Rothemberg CJ. The rise and fall of estrogen therapy: The history of HRT. http://leda.law. harvard.edu/leda/data/711/Rothenberg05.pdf
3. Hammar M, Berg G, Lindgren R. Does physical exercise influence the frequency of postmenopausal hot flushes? Acta Obstet Gynecol Scand 1990;69:409-12
4. Thurston RC, Joffe H, Soares CN, Harlow BL. Physical activity and risk of vasomotor symptoms in women with and without a history of depression: results from the Harvard Study of Moods and Cycles. Menopause 2006;13:553-60
5. Greendale GA, Gold EB. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy? Am J Med 2005;118(Suppl 12B):148-54
6. Freedman RR. Current best treatment for hot flashes. Menopause Management 2006;15:20-5
7. Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003;44(Suppl 1):S67-77
8. Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006;145:869-79
9. Pockaj BA, Gallagher JG, Loprinzi CL, et al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 2006;24:2836-41
10. Frei-Kleiner S, Schaffner W, Rahlfs VW, Bodmer Ch, Birkhauser M. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas 2005;51:397-404
11. Jacobson JS, Troxel AB, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001;19:2739-45
12. Cassidy A, Albertazzi P, Lise Nielsen I, et al. Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women. Proc Nutr Soc 2006;65:76-92
13. Low Dog T. Menopause: a review of botanical dietary supplements. Am J Med 2005;118 (Suppl 12B):98-108
14. Schiff I, Tulchinsky D, Cramer D, Rayan KJ. Oral medroxyprogesterone in the treatment of postmenopausal symptom. JAMA 1980;244:1443-5
15. Aslaksen K, Frankendal B. Effect of oral medroxyprogesterone acetate on menopausal symptoms in patients with endometrial carcinoma. Acta Obstet Gynecol Scand 1982;61:423-8
16. Bertelli G, Venturini M, Del Mastro L, et al. Intramuscular depot medroxyprogesterone versus oral mergestrol for the control of postmenopausal hot flushes in breast cancer patients: a randomized study. Ann Oncol 2002;13:883-8
17. Loprizi CL, Michalak JC, Quella SK, et al. Mergestrol acetate for the prevention of hot flushes. N Engl J Med 1994;331:347-52
18. Women's Health Initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33
19. Leonetti HB, Longo S, Anasti JN. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 1999;94:225-8
20. Komesaroff PA, Black CV, Cable V, Sudhir K. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 2001;4:144-50
21. Guttuso TJ Jr. Gabapentin's effects on hot flashes and hypothermia. Neurology 2000;54:2161-3
22. Albertazzi P, Bottazzi M, Purdie DW. Gabapentin for the management of hot flushes: a case series. Menopause 2003;10:214-17
23. Guttuso T Jr, Kurlan R, McDermott MP, Kieburtz K. Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstet Gynecol 2003;101:337-45
24. Pandya KJ, Morrow GR, Roscoe JA, et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet 2005;366:818-24
25. Loprinzi CL, Kugler JW, Barton DL, et al. Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. J Clin Oncol 2007;25:308-12
26. Reddy SY, Warner H, Guttuso T Jr, et al. Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial. Obstet Gynecol 2006;108:41-8
27. http://www.mhra.gov.uk/home/idcplg?IdcService= SS_GET_PAGE&nodeId= 433&within=Yes& keywords=venlafaxine
28. Albertazzi P. Noradrenergic and serotonergic modulation to treat vasomotor symptoms. J Br Menopause Soc 2006;12:7-11
29. Evans ML, Pritts E, Vittinghoff E, McClish K, Morgan KS, Jaffe RB. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial. Obstet Gynecol 2005;105:161-6
30. Wyeth submits two new drug applications for women's health therapies. 06/26/2006 http://www. wyeth.com/news?nav=display&navTo=/wyeth_ html/home/news/pressreleases/2006/1151332793019.html
31. Suvanto-Luukkonen E, Koivunen R, Sundstrom H, et al. Citalopram and fluoxetine in the treatment of post-menopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause 2005;12:18-26
32. Stearns V, Slack R, Greep N, et al. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol 2005;23:6919-30
33. Loprinzi CL, Flynn PJ, Carpenter LA, et al. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. J Palliat Med 2005;8:924-30
34. Gordon PR, Kerwin JP, Boesen KG, Senf J. Sertraline to treat hot flashes: a randomized controlled, double-blind, crossover trial in a general population. Menopause 2006;13:546-8